HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masato Yoneda Selected Research

Endotoxins

10/2022A cross-sectional study assessing the relationship between non-alcoholic fatty liver disease and periodontal disease.
7/2021The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target.
1/2021Endotoxins and Non-Alcoholic Fatty Liver Disease.
3/2020Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial.
1/2018Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin.
1/2018[Gut microbiota and nonalcoholic steatohepatitis].
7/2012Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masato Yoneda Research Topics

Disease

98Non-alcoholic Fatty Liver Disease
03/2024 - 10/2006
52Fibrosis (Cirrhosis)
03/2024 - 06/2005
24Neoplasms (Cancer)
01/2024 - 09/2006
20Liver Cirrhosis (Hepatic Cirrhosis)
03/2024 - 08/2010
20Inflammation (Inflammations)
10/2022 - 04/2005
18Insulin Resistance
11/2023 - 04/2005
16Obesity
02/2023 - 01/2007
15Alcoholic Fatty Liver
12/2021 - 04/2005
14Liver Diseases (Liver Disease)
11/2023 - 10/2007
13Hepatocellular Carcinoma (Hepatoma)
01/2024 - 12/2004
13Carcinogenesis
11/2023 - 10/2007
12Type 2 Diabetes Mellitus (MODY)
01/2021 - 06/2006
10Hemorrhage
01/2024 - 01/2007
8Colorectal Neoplasms (Colorectal Cancer)
10/2022 - 02/2009
7Aberrant Crypt Foci
10/2022 - 12/2008
7Body Weight (Weight, Body)
01/2022 - 10/2005
6Constipation
08/2022 - 01/2018
6Dyslipidemias (Dyslipidemia)
08/2019 - 06/2010
6Colonic Neoplasms (Colon Cancer)
07/2009 - 04/2005
5Fatty Liver
11/2023 - 02/2011
5Hypertension (High Blood Pressure)
12/2022 - 12/2007
5Gastroesophageal Reflux (GERD)
11/2020 - 09/2008
5Infections
01/2016 - 03/2005
4Periodontitis
11/2022 - 01/2014
4Diabetes Mellitus
01/2022 - 12/2007
4Pancreatic Neoplasms (Pancreatic Cancer)
11/2011 - 02/2006
3Ascites
03/2024 - 08/2023
3Liver Failure
10/2023 - 07/2021
3Dysbiosis
07/2021 - 01/2018
3Adenocarcinoma
11/2011 - 01/2011
3Autoimmune Pancreatitis
06/2011 - 01/2010
3Polyps
07/2010 - 01/2007
2Hepatic Encephalopathy
01/2024 - 08/2023
2Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction)
01/2024 - 07/2023
2Disease Progression
07/2023 - 07/2021
2Acute Liver Failure (Fulminant Hepatic Failure)
06/2023 - 09/2021
2Esophageal Neoplasms (Esophageal Cancer)
06/2023 - 09/2006

Drug/Important Bio-Agent (IBA)

21Biomarkers (Surrogate Marker)IBA
08/2023 - 05/2007
15Alanine Transaminase (SGPT)IBA
11/2023 - 05/2007
13Insulin (Novolin)FDA Link
02/2023 - 10/2005
12Glucose (Dextrose)FDA LinkGeneric
03/2024 - 10/2005
12LipidsIBA
11/2023 - 01/2007
11Proteins (Proteins, Gene)FDA Link
02/2024 - 01/2007
11Triglycerides (Triacylglycerol)IBA
11/2023 - 01/2007
10Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2023 - 05/2007
9Collagen Type IV (Type IV Collagen)IBA
03/2023 - 05/2007
9Messenger RNA (mRNA)IBA
10/2021 - 06/2005
8AdiponectinIBA
02/2023 - 01/2007
8Protons (Proton)IBA
12/2022 - 01/2020
8Ferritins (Ferritin)IBA
10/2022 - 10/2005
8Pioglitazone (Actos)FDA Link
01/2022 - 10/2006
8HDL CholesterolIBA
01/2016 - 01/2007
7EndotoxinsIBA
10/2022 - 07/2012
7Capsules (Microcapsules)IBA
01/2022 - 01/2007
7Indicators and Reagents (Reagents)IBA
01/2022 - 10/2005
7LDL CholesterolIBA
06/2020 - 01/2007
6Therapeutic UsesIBA
03/2021 - 07/2012
6PPAR gammaIBA
12/2008 - 08/2004
5Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2024 - 01/2012
5CholesterolIBA
11/2023 - 01/2008
5oxidized low density lipoproteinIBA
06/2020 - 01/2007
5LeptinIBA
01/2014 - 05/2009
4RNA (Ribonucleic Acid)IBA
11/2023 - 10/2007
4Bile Acids and Salts (Bile Acids)IBA
11/2023 - 06/2020
4elobixibatIBA
11/2023 - 01/2020
4AcidsIBA
10/2023 - 09/2008
4HDL LipoproteinsIBA
10/2022 - 01/2008
4Transaminases (Aminotransferases)IBA
12/2021 - 10/2007
4nasIBA
06/2020 - 11/2011
4Hemoglobins (Hemoglobin)IBA
07/2018 - 01/2008
4Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2015 - 10/2009
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2012 - 01/2009
4microsomal triglyceride transfer proteinIBA
08/2012 - 09/2009
4LigandsIBA
11/2011 - 04/2005
3Small Interfering RNA (siRNA)IBA
11/2023 - 01/2007
3Serum AlbuminIBA
04/2023 - 08/2014
3Glucagon-Like Peptide 1 (GLP 1)IBA
01/2022 - 03/2020
36- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA
01/2022 - 03/2020
3IronIBA
01/2022 - 10/2005
3LubiprostoneFDA Link
07/2021 - 01/2018
3Ethanol (Ethyl Alcohol)IBA
07/2021 - 12/2008
3GemcitabineFDA Link
04/2021 - 02/2006
3Hypoglycemic Agents (Hypoglycemics)IBA
06/2020 - 07/2010
3Sitagliptin Phosphate (Januvia)FDA Link
07/2018 - 11/2011
3LipopolysaccharidesIBA
02/2016 - 07/2012
3DNA (Deoxyribonucleic Acid)IBA
01/2016 - 05/2014
3Choline (Choline Chloride)IBA
02/2014 - 02/2010
3Immunoglobulin G (IgG)IBA
06/2011 - 12/2007
3Ezetimibe (Zetia)FDA Link
03/2011 - 09/2009
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
09/2006 - 08/2004
2obeticholic acidIBA
03/2024 - 06/2020
2SodiumIBA
03/2024 - 01/2022
2Cholestyramine Resin (Questran)FDA LinkGeneric
11/2023 - 01/2020
2Immune Checkpoint InhibitorsIBA
10/2023 - 06/2023

Therapy/Procedure

28Therapeutics
03/2024 - 12/2004
13Drug Therapy (Chemotherapy)
03/2024 - 02/2006
8Liver Transplantation
01/2024 - 08/2020
3Aftercare (After-Treatment)
03/2021 - 01/2011
3Gastrostomy
12/2014 - 01/2007
2Palliative Care (Palliative Therapy)
03/2024 - 07/2023